Nombre del producto:5,7-dichloro-3-isopropylpyrazolo[1,5-a]pyrimidine

IUPAC Name:5,7-dichloro-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidine

CAS:771510-32-8
Fórmula molecular:C9H9Cl2N3
Pureza:95%+
Número de catálogo:CM151764
Peso molecular:230.09

Unidad de embalaje Stock disponible Precio($) Cantidad
CM151764-100mg in stock Ūdž
CM151764-250mg in stock ǫƴ
CM151764-1g in stock ŸdžŸ
CM151764-5g in stock ƐŪǫ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :771510-32-8
Fórmula molecular:C9H9Cl2N3
Punto de fusión:-
Código de sonrisas:CC(C)C1=C2N=C(Cl)C=C(Cl)N2N=C1
Densidad:
Número de catálogo:CM151764
Peso molecular:230.09
Punto de ebullición:
Nº Mdl:MFCD12923044
Almacenamiento:Store at 2-8°C.

Category Infos

Pyrazolopyrimidines
Pyrazolopyrimidine scaffolds are one of the most important heterocyclic compounds in drug discovery. This scaffold has various biological activities, among which anticancer is an important one.

Column Infos

Samuraciclib
Carrick Therapeutics’ Phase 2 Clinical Trial of Samuraciclib combined with Fulvestrant has dosed its first patient. The study targets patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer. Samuraciclib is a selective oral, first-in-class inhibitor of CDK7. It is involved in the regulation of cancer-causing genes, promotion of uncontrolled cell cycle progression, and increase in resistance to anti-hormone therapy. The comb previously receives the Fast Track Designation from the U.S. FDA.

Related Products